InvestorsHub Logo
Followers 25
Posts 676
Boards Moderated 0
Alias Born 08/17/2010

Re: None

Monday, 04/13/2015 10:25:31 AM

Monday, April 13, 2015 10:25:31 AM

Post# of 138
Pay attention to CMXC this morning folks! You ‘ve probably known biotech is exploding this year for any company in this field.

I get particularly excited about biotech companies, but I am absolutely overjoyed when they are actually conducting clinical trials. You can probably guess why; biotech companies thrive on clinical trials because the sooner they get them done, the sooner they can get FDA approval and make millions, sometimes in even billions of dollars in revenues.

The story is no different with my latest tip. CMXC comes to the market with a unique e-balance technology that helps in the therapeutic treatment of conditions such as diabetes. The company has just completed phase 1 pilot clinical trial and going by the release, it looks like CMXC is on its way to really big things.

The good news from your perspective is that CMXC is not as expensive as you’d expect – it’s not there yet, at least. This gives more time for you to capitalize.

To learn more about CMXC please visit their website: www.cellmedx.com

CMXC is trading 28 cents and has remarkable upside potential. The 12-month high is a lofty 1.15 and volatility levels are now starting to sing. In terms of timing, you have a very good entry opportunity, so don’t let it slip!

Cell MedX Corp. [OTCBB: CMXC] is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. Through its wholly owned subsidiary, Avyonce Cosmedics Inc., CMXC is also engaged in the resale and marketing of spa technology and equipment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CMXC News